• Aucun résultat trouvé

Hybrid metal-polymer nanoparticles as promising radiosensitizers for cancer treatment

N/A
N/A
Protected

Academic year: 2021

Partager "Hybrid metal-polymer nanoparticles as promising radiosensitizers for cancer treatment"

Copied!
2
0
0

Texte intégral

(1)

HAL Id: cea-02341194

https://hal-cea.archives-ouvertes.fr/cea-02341194

Submitted on 31 Oct 2019

HAL is a multi-disciplinary open access archive for the deposit and dissemination of sci-entific research documents, whether they are pub-lished or not. The documents may come from teaching and research institutions in France or abroad, or from public or private research centers.

L’archive ouverte pluridisciplinaire HAL, est destinée au dépôt et à la diffusion de documents scientifiques de niveau recherche, publiés ou non, émanant des établissements d’enseignement et de recherche français ou étrangers, des laboratoires publics ou privés.

Hybrid metal-polymer nanoparticles as promising

radiosensitizers for cancer treatment

Marine Le Goas, A. Paquirissamy, B. Cambien, Thierry Pourcher, G. Carrot,

Jean Philippe Renault, Serge Palacin

To cite this version:

Marine Le Goas, A. Paquirissamy, B. Cambien, Thierry Pourcher, G. Carrot, et al.. Hybrid metal-polymer nanoparticles as promising radiosensitizers for cancer treatment. IMBG 2017, Sep 2017, Villard de Lans, France. �cea-02341194�

(2)

Poster IMBG 2017 – Villars de lans – 11-15 Septembre 2017

Hybrid metal-polymer nanoparticles as promising radiosensitizers

for cancer treatment

Marine Le Goasa, A. Paquirissamya, B. Cambienb Thierry Pourcher b, G. Carrot a, JP. Renault a and S. Palacin a.

a NIMBE UMR 3685, CEA, CNRS, Université Paris-Saclay, France

b TIRO, UMRE 4320, iBEB, DSV, CEA, Université de Nice-Sophia Antipolis, France

marine.le-goas@cea.fr

Nanotechnologies are being widely studied for medical applications, both diagnosis and treatment. They have already shown great promise, especially to treat cancer through various strategies such as chemotherapy, photothermal therapy or radiation therapies. High-Z elements nanoparticles are of particular interest for the latter, considering their ability to amplify the damaging effects of both photon and ion radiations: gold, platinum and gadolinium are amongst the most investigated elements. [1][2]

A well-controlled synthesis is key to obtain stable and scalable nano-objects. Here, various polymers were grafted onto metallic nanoparticles to improve stability and biocompatibility and to facilitate subsequent functionalization. Advanced methods of characterization attested to the robustness and reproducibility of the synthesis procedure. Moreover, promising results were obtained regarding the radioenhancing properties of these hybrid nanocompounds.

Polymers mainly synthesized via controlled radical polymerization were grafted onto gold and platinum nanoparticles by a “grafting to” or “grafting from” method. Subsequent grafting of a chemotherapy drug onto the polymer corona was also successfully carried out.

The resulting nano-objects were fully characterized by thermogravimetric analysis, transmission electronic microscopy and small-angle x-ray scattering. Small-angle neutron scattering was also performed, taking advantage of possible contrast matching. The impact of various radiation doses on the nanoparticles structure was studied. Finally, radiosensitizing effects were investigated through in vitro tests. Under irradiation, uncoupling and cleavage of polymer chains were demonstrated, leading to an overall size reduction of the hybrid nano-objects. The location of target sites during irradiation was determined and helped to better understand the underlying mechanism of the radiosensitization assessed by the in vitro results. The synthesized nano-objects have therefore shown great potential to enhance radiation cancer treatment. Their stability and controlled surface chemistry will allow to develop multiple strategies to further improve their radiosensitizing effect and in vitro behavior. In vivo tests are currently under study, as well as experiments regarding radioenhancement for proton therapy.

[1] T. Schlathölter et al., Int. J. Nanomedicine, vol. 11, p. 1549 1556, avr. 2016. [2] K. Haume et al., Cancer Nanotechnol., vol. 7, no 1, p. 8, nov. 2016.

Références

Documents relatifs

Herein we report on construction of nanomaterial containing nanodiamonds entrapped in ethylene and ethenylene-bridged periodic mesoporous organosilica nanoparticles

KEYWORDS: magnetosomes, cancer, natural iron oxide nanoparticle, alternating magnetic field, 40.. magnetic hyperthermia, nano-oncology, glioblastoma, GBM, anti-tumor

2950 Figure 3: Metabolic activity of PC3 cells incubated (a) with free alendronate (black curve) and Au@alendronate NPs (blue curve), (b) with Au@alen- dronate NPs under the

Herein, we tackle these issues and report on a global approach based on the facile derivatization of Ptx followed by subsequent “drug-initiated” RDRP to

Notre étude consiste à décrire l’information transmise au moyen des lettres de transfert remises aux patients quittant l’unité de cardiologie de l’Hôpital de l’Enfant-Jésus

Jean Bellavance, FAE; Lyne Boileau, Carrefour de la réussite au collégial; Monique Brodeur, Association des doyens et directeurs pour l’étude et la recherche en éducation au Québec

The aim of this thesis was to develop two different drug delivery systems for prostate cancer applications: one metallic, using pegylated gold nanoparticles and

trimesate nanoMOFs acted as “Trojan horses” carrying the drug inside cancer cells to eradicate